Skip to main content

Pyoderma Gangrenosum Successfully Treated with Cyclosporin A

  • Chapter
Rheumaderm

Abstract

The subjects of the study are a 48-year old male and a 50-year female patient with the idiopathic form of pyoderma gangrenosum. Both patients were treated with Cyclosporin A (Sandimmun) as monotherapy. Complete resolution was achieved after three months’ treatment. No serious side-effects were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occuring in adults. Arch Dermatol 22:655–680 (1930)

    Article  Google Scholar 

  2. Jones RR: Cutaneous manifestations of paraproteinemia. Br J Dermatol. 104:209–220 (1981)

    Article  PubMed  CAS  Google Scholar 

  3. Borel JF. In: Kahan B, ed. Cyclosporine:Nature of the Agent and its Immunologic Actions. New York, NY:Guine and Stratton 722–730 (1988)

    Google Scholar 

  4. Furue M, Gaspari A, Katz S. The effect of cyclosporin A on epidermal cells II: cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 90:796–800 (1988).

    Article  PubMed  CAS  Google Scholar 

  5. Elgart G, Larson K, Stover P, Davis B. Effective treatment of pyoderma gangrenosum with cyclosporin: a report of five cases. J Invest Dermatol. 92:424 (1989)

    Google Scholar 

  6. Magid ML, Gold MH. Treatment of recalcitrant pyoderma gangrenosum with cyclosporine. J Am Acad Dermatol. 20:293–294 (1989).

    Article  PubMed  CAS  Google Scholar 

  7. Curley RK, Mcfarlane AW, Vickers CFH. Pyoderma Gangrenosum treated with Cyclosporine. Br J Dermatol. 113:601–604(1985).

    Article  PubMed  CAS  Google Scholar 

  8. Ho VC, Dutz J, Gulliver W, Lauzon G. Canadian experience of cyclosporin A (Sandimmun and Sandimmun Neoral) in the treatment of refractory pyoderma gangrenosum. International Congress on Immunointervention. The Role of Neoral in Immune-Based Diseases. Rome, Italy, June 1996 (Abstracts)

    Google Scholar 

  9. Mork NJ, Mork G, Koss-Harnes D. Severe pyoderma gangrenosum successfully treated with cyclosporin. International Congress on Immunointervention. The Role of Neoral in Immune-Based Diseases. Rome, Italy, June 1996 (Abstracts)

    Google Scholar 

  10. Wang DZ, McCafrey PG, Rao A. The Cyclosporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system. Ann New York Acad Sci 766:182–194 (1995)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. T. V’lčkova-Laskoska .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

V’lčkova-Laskoska, M.T., Laskoski, D.S., Caca-Biljanovska, N.G., Darkoska, J.S. (1999). Pyoderma Gangrenosum Successfully Treated with Cyclosporin A. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_81

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4857-7_81

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7203-5

  • Online ISBN: 978-1-4615-4857-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics